Cargando…
Rcn3 Suppression Was Responsible for Partial Relief of Emphysema as Shown by Specific Type II Alveolar Epithelial Cell Rcn3 CKO Mouse Model
BACKGROUND: Chronic obstructive pulmonary disease (COPD), characterized by irreversible airflow limitation, is a highly prevalent lung disease worldwide and imposes increasing disease burdens globally. Emphysema is one of the primary pathological features contributing to the irreversible decline of...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7847372/ https://www.ncbi.nlm.nih.gov/pubmed/33531801 http://dx.doi.org/10.2147/COPD.S272711 |
_version_ | 1783644919501422592 |
---|---|
author | Zhang, Qianyu Wang, Tong Jin, Jiawei Shi, Xiaoqian Huang, Aiben Ma, Zhenru Li, Jiujie Wang, Shiyu Z. Ma, Runlin Fang, Qiuhong |
author_facet | Zhang, Qianyu Wang, Tong Jin, Jiawei Shi, Xiaoqian Huang, Aiben Ma, Zhenru Li, Jiujie Wang, Shiyu Z. Ma, Runlin Fang, Qiuhong |
author_sort | Zhang, Qianyu |
collection | PubMed |
description | BACKGROUND: Chronic obstructive pulmonary disease (COPD), characterized by irreversible airflow limitation, is a highly prevalent lung disease worldwide and imposes increasing disease burdens globally. Emphysema is one of the primary pathological features contributing to the irreversible decline of pulmonary function in COPD patients, but the pathogenetic mechanisms remain unclear. Reticulocalbin 3 (Rcn3) is an endoplasmic reticulum (ER) lumen protein localized in the secretory pathway of living cells. Rcn3 in type II alveolar epithelial cell (AECIIs) has been reported to play a critical role in regulating perinatal lung development and bleomycin-induced lung injury-repair processes. We hypothesized that Rcn3 deficiency is associated with the development of emphysema during COPD, which is associated with the dysfunction of injury-repair modulated by alveolar epithelial cells. MATERIALS AND METHODS: We examined Rcn3 expression in lung specimens from COPD patients and non-COPD control patients undergoing lung lobectomy or pneumonectomy. Two mouse models of emphysema were established by cigarette smoke (CS) exposure and intratracheal instillation of porcine pancreatic elastase (PPE). Rcn3 expression was detected in the lung tissues from these mice. Furthermore, conditional knockout (CKO) mice with Rcn3 deletion specific to AECIIs were used to explore the role of Rcn3 in PPE-induced emphysema progression. Rcn3 protein expression in lung tissues was evaluated by Western blot and immunohistochemistry. Rcn3 mRNA expression in lung tissues was detected by qPCR. RESULTS: Rcn3 expression was significantly increased in the lung specimens from COPD patients versus non-COPD patients and the level of Rcn3 increase was associated with the degree of emphysema. Rcn3 expression were also significantly up-regulated in both CS-induced and PPE-induced emphysematous mouse lungs. Moreover, the selective ablation of Rcn3 in AECIIs significantly alleviated severity of the mouse emphysema in response to intratracheal installation of PPE. CONCLUSION: Our data, for the first time, indicated that suppression of Rcn3 expression in AECIIs has a beneficial effect on PPE-induced emphysema. |
format | Online Article Text |
id | pubmed-7847372 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-78473722021-02-01 Rcn3 Suppression Was Responsible for Partial Relief of Emphysema as Shown by Specific Type II Alveolar Epithelial Cell Rcn3 CKO Mouse Model Zhang, Qianyu Wang, Tong Jin, Jiawei Shi, Xiaoqian Huang, Aiben Ma, Zhenru Li, Jiujie Wang, Shiyu Z. Ma, Runlin Fang, Qiuhong Int J Chron Obstruct Pulmon Dis Original Research BACKGROUND: Chronic obstructive pulmonary disease (COPD), characterized by irreversible airflow limitation, is a highly prevalent lung disease worldwide and imposes increasing disease burdens globally. Emphysema is one of the primary pathological features contributing to the irreversible decline of pulmonary function in COPD patients, but the pathogenetic mechanisms remain unclear. Reticulocalbin 3 (Rcn3) is an endoplasmic reticulum (ER) lumen protein localized in the secretory pathway of living cells. Rcn3 in type II alveolar epithelial cell (AECIIs) has been reported to play a critical role in regulating perinatal lung development and bleomycin-induced lung injury-repair processes. We hypothesized that Rcn3 deficiency is associated with the development of emphysema during COPD, which is associated with the dysfunction of injury-repair modulated by alveolar epithelial cells. MATERIALS AND METHODS: We examined Rcn3 expression in lung specimens from COPD patients and non-COPD control patients undergoing lung lobectomy or pneumonectomy. Two mouse models of emphysema were established by cigarette smoke (CS) exposure and intratracheal instillation of porcine pancreatic elastase (PPE). Rcn3 expression was detected in the lung tissues from these mice. Furthermore, conditional knockout (CKO) mice with Rcn3 deletion specific to AECIIs were used to explore the role of Rcn3 in PPE-induced emphysema progression. Rcn3 protein expression in lung tissues was evaluated by Western blot and immunohistochemistry. Rcn3 mRNA expression in lung tissues was detected by qPCR. RESULTS: Rcn3 expression was significantly increased in the lung specimens from COPD patients versus non-COPD patients and the level of Rcn3 increase was associated with the degree of emphysema. Rcn3 expression were also significantly up-regulated in both CS-induced and PPE-induced emphysematous mouse lungs. Moreover, the selective ablation of Rcn3 in AECIIs significantly alleviated severity of the mouse emphysema in response to intratracheal installation of PPE. CONCLUSION: Our data, for the first time, indicated that suppression of Rcn3 expression in AECIIs has a beneficial effect on PPE-induced emphysema. Dove 2021-01-26 /pmc/articles/PMC7847372/ /pubmed/33531801 http://dx.doi.org/10.2147/COPD.S272711 Text en © 2021 Zhang et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Original Research Zhang, Qianyu Wang, Tong Jin, Jiawei Shi, Xiaoqian Huang, Aiben Ma, Zhenru Li, Jiujie Wang, Shiyu Z. Ma, Runlin Fang, Qiuhong Rcn3 Suppression Was Responsible for Partial Relief of Emphysema as Shown by Specific Type II Alveolar Epithelial Cell Rcn3 CKO Mouse Model |
title | Rcn3 Suppression Was Responsible for Partial Relief of Emphysema as Shown by Specific Type II Alveolar Epithelial Cell Rcn3 CKO Mouse Model |
title_full | Rcn3 Suppression Was Responsible for Partial Relief of Emphysema as Shown by Specific Type II Alveolar Epithelial Cell Rcn3 CKO Mouse Model |
title_fullStr | Rcn3 Suppression Was Responsible for Partial Relief of Emphysema as Shown by Specific Type II Alveolar Epithelial Cell Rcn3 CKO Mouse Model |
title_full_unstemmed | Rcn3 Suppression Was Responsible for Partial Relief of Emphysema as Shown by Specific Type II Alveolar Epithelial Cell Rcn3 CKO Mouse Model |
title_short | Rcn3 Suppression Was Responsible for Partial Relief of Emphysema as Shown by Specific Type II Alveolar Epithelial Cell Rcn3 CKO Mouse Model |
title_sort | rcn3 suppression was responsible for partial relief of emphysema as shown by specific type ii alveolar epithelial cell rcn3 cko mouse model |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7847372/ https://www.ncbi.nlm.nih.gov/pubmed/33531801 http://dx.doi.org/10.2147/COPD.S272711 |
work_keys_str_mv | AT zhangqianyu rcn3suppressionwasresponsibleforpartialreliefofemphysemaasshownbyspecifictypeiialveolarepithelialcellrcn3ckomousemodel AT wangtong rcn3suppressionwasresponsibleforpartialreliefofemphysemaasshownbyspecifictypeiialveolarepithelialcellrcn3ckomousemodel AT jinjiawei rcn3suppressionwasresponsibleforpartialreliefofemphysemaasshownbyspecifictypeiialveolarepithelialcellrcn3ckomousemodel AT shixiaoqian rcn3suppressionwasresponsibleforpartialreliefofemphysemaasshownbyspecifictypeiialveolarepithelialcellrcn3ckomousemodel AT huangaiben rcn3suppressionwasresponsibleforpartialreliefofemphysemaasshownbyspecifictypeiialveolarepithelialcellrcn3ckomousemodel AT mazhenru rcn3suppressionwasresponsibleforpartialreliefofemphysemaasshownbyspecifictypeiialveolarepithelialcellrcn3ckomousemodel AT lijiujie rcn3suppressionwasresponsibleforpartialreliefofemphysemaasshownbyspecifictypeiialveolarepithelialcellrcn3ckomousemodel AT wangshiyu rcn3suppressionwasresponsibleforpartialreliefofemphysemaasshownbyspecifictypeiialveolarepithelialcellrcn3ckomousemodel AT zmarunlin rcn3suppressionwasresponsibleforpartialreliefofemphysemaasshownbyspecifictypeiialveolarepithelialcellrcn3ckomousemodel AT fangqiuhong rcn3suppressionwasresponsibleforpartialreliefofemphysemaasshownbyspecifictypeiialveolarepithelialcellrcn3ckomousemodel |